Why BridgeBio Stopped Galactosemia Gene Therapy

from The Galactosemia Podcast · host Ryan and Jill

BridgeBio recently stopped their research and development of gene therapy for Galactosemia. This came as a shock to many of us. I talked to the CEO of BridgeBio on the phone, and in this episode I report back what he told me.

Episode metadata supplied by the publisher feed · Published Feb 11, 2026

Embed this episode

Attribution link and audio player

Ready to play

Why BridgeBio Stopped Galactosemia Gene Therapy

0:00 18:34

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of The Galactosemia Podcast?

This episode is 18 minutes long.

When was this The Galactosemia Podcast episode published?

This episode was published on February 11, 2026.

Can I download this The Galactosemia Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!